. Author manuscript; available in PMC: 2022 Jan 1.

Published in final edited form as: Ann Surg Oncol. 2020 May 14;28(1):570–575. doi: 10.1245/s10434-020-08582-8

TABLE 4.

Impact of surveillance imaging interval on management of liposarcoma recurrence following macroscopic complete (R0/R1) surgical resection of primary retroperitoneal well-differentiated liposarcoma (n = 88)

Impact on management of liposarcoma recurrence	Imaging frequency
Impact on management of liposarcoma recurrence	q4 months (vs q3 months), number of patients, (%)	q6 months (vs q3 months), number of patients (%)
No impact	84 (95.5%)	80 (90.9%)
Delayed initiation of treatment (chemotherapy)	1 (1.1%)	1 (1.1%)
Unknown impact	3 (3.4%)	7 (8.0%)